|
SG110994G
|
|
Method of treating for interstitial cystitis
|
|
WO9302044A1
|
|
Acyclic 6-phenylselenenyl pyrimidine nucleosides
|
|
WO9218126A1
|
|
Method of improving donor organ function and preventing reperfusion injury
|
|
WO9215305A1
|
|
Method of treatment for asthma, bronchospasm and obstructive lung disease
|
|
US5120724A
|
|
Aldosterone biosynthesis inhibitor
|
|
US4994466A
|
|
Method of treatment for multiple sclerosis
|
|
US4923875A
|
|
Method for treatment of mast cell-mediated dermatologic disorders
|
|
EP0368972A1
|
|
Method of safely providing anesthesia or conscious sedation.
|
|
EP0376999A1
|
|
Method of reversing the side effects of epidural analgesics
|
|
US4873076A
|
|
Method of safely providing anesthesia or conscious sedation
|
|
AU2855189A
|
|
Method of treating fibrotic disorders
|
|
US4863928A
|
|
Method of treatment for arthritic and inflammatory diseases
|
|
US4857533A
|
|
Method of treatment for autoimmune diseases
|
|
US4877791A
|
|
Method of treatment for interestitial cystitis
|
|
US4874613A
|
|
Taste concealing pharmaceutical dosage unit
|
|
US4880813A
|
|
Method of treatment for allergic rhinitis
|
|
IE880905L
|
|
Anti-viral compounds.
|
|
AU1573988A
|
|
Arrangement for and method of administering a pharmaceutical preparation
|
|
US5009894A
|
|
Arrangement for and method of administering a pharmaceutical preparation
|
|
AU1032988A
|
|
Glucuronic acid derivatives of opioid antagonists
|
